MedPath

Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta

Completed
Conditions
Cardiopulmonary Arrest
Aortic Aneurysm, Thoracic
Aortic Diseases
Coronary Artery Disease
Registration Number
NCT02876263
Lead Sponsor
University of Helsinki
Brief Summary

The aim of this prospective, explorative study of noninvasive neuromonitoring was to search potential and practical methods associated with neurological outcome in the perioperative and immediate postoperative setting of surgery of the thoracic aorta. These methods include abbreviated EEG monitoring, near-infrared spectroscopy, transcranial Doppler ultrasound and biochemical markers associated with neuronal damage.

Detailed Description

For the purpose of this study, 30 patients undergoing aortic surgery via a median sternotomy (n=29; 97%) or left thoracotomy (n=1; 3%) and cardiopulmonary bypass with deep hypothermic cardiac arrest were recruited. All patients were operated under deep hypothermia and circulatory arrest, with optional selective cerebral perfusion during circulatory arrest. Active patient recruitment started from September 2007 and ended in May 2011. All patients were monitored with a bilateral fronto-temporal four channel abbreviated EEG, a bilateral frontal two-channel near-infrared spectroscopy, postoperative transcranial Doppler ultrasound evaluation of median artery circulation and postoperative biochemical neuromarkers. The study montage was set up by a dedicated research nurse, who also performed the transcranial Doppler measurements. The neuromonitoring data were not used at the time to guide therapeutic decisions, with the exception of near-infrared spectroscopy monitoring.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Patients scheduled for elective or emergency surgery on the thoracic aorta (study group) or coronary heart disease (control groups)
  • Informed consent from patient or next of kin
Exclusion Criteria
  • Age under 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Neurological outcomeMonitoring period from anesthesia induction to 48 hours after end of surgery

Permanent neurological damage or death within monitoring period (up to 48 h after surgery)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Helsinki University Central Hospital, Department of Cardiac Surgery

🇫🇮

Helsinki, Uudenmaan lääni, Finland

Helsinki University Central Hospital, Department of Cardiac Surgery
🇫🇮Helsinki, Uudenmaan lääni, Finland
© Copyright 2025. All Rights Reserved by MedPath